Brittany Schlater dominated the 2024 CPU Canadian National Championships and unofficially broke the Raw Deadlift IPF World ...

Insilico Medicine has announced positive preliminary results from its Phase IIa clinical trial of ISM001-055, a small ...

A University of Colorado professor won the 2024 Alton Ochsner Award for his work on disease risk factors for idiopathic ...

The positive phase 3 results showed improved lung function with nerandomilast vs placebo at 52 weeks in idiopathic pulmonary ...

Ade Omisakin has managed to demolish the U83KG IPF Raw Total World Record at the 2024 IPF Western European Powerlifting ...

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...

The Phase III trial evaluating nerandomilast as a treatment for idiopathic pulmonary fibrosis met its primary endpoint.

On Saturday, September 21, the Ivy Pearl Foundation (IPF) will hold its 25th Anniversary celebration at the YWCA ...

Findings of a systematic review highlight the need for standardized assessment tools and targeted treatments for chronic ...

FIRST COLLABORATIVE EFFORT UNDER NEW AGREEMENT ALLEN, TX / ACCESSWIRE / September 18, 2024 / (OTC PINK:ENZC) ("enzolytics.com ...

Leerink Partners analyst Faisal Khurshid has maintained their bullish stance on PLRX stock, giving a Buy rating on September 13. Faisal ...